CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The Duo project focuses on developing a minimally invasive device to treat tricuspid regurgitation, a condition caused by heart failure. This innovative technology aims to restore proper valve function without the risks associated with traditional open-heart surgery, ultimately improving patient outcomes and quality of…
Heart failure is the leading cause of death, affecting 15 million patients across Europe and the US.
In patients with heart failure, the right heart expands, resulting in the tricuspid valve not closing properly and blood leaking backwards.
This is called tricuspid regurgitation.
The tricuspid valve has remained largely untreated due to unique functional and anatomical challenges.
Currently less than 1% of patients are surgically treated due to the fact that open-heart surgery is still the only…
CROIVALVE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
INNOVATIVE CATHETER SOLUTIONS LIMITED
Ireland, Galway
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Belgium, Herzele
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Israel, Yavne
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
